The only one thing I'll point out is that you won't see the gap between receipts and operating costs widen substantially whilst a medicinal cannabis company is growing rapidly. That's because the costs of maintaining the next (bigger) crop are included in the product costs in the 4C while receipts is the money that's been received from a previous (smaller) crop. That's why I like to see the fair value gain on bios. When ECS stops expanding the receipts and costs will be determined at the same level of production and there will be a huge spike in the gap between the two.
- Forums
- ASX - By Stock
- ECS
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-45
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECS (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.19M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 472397 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.018 |
12 | 3862905 | 0.017 |
10 | 2024563 | 0.016 |
6 | 399999 | 0.015 |
4 | 1194353 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 472397 | 5 |
0.020 | 546158 | 6 |
0.021 | 1422157 | 6 |
0.022 | 752190 | 5 |
0.023 | 824149 | 5 |
Last trade - 10.32am 24/07/2024 (20 minute delay) ? |
Featured News
ECS (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online